Drug Discovery & Development

Leading Pulmonologists in India have started using Molnupiravir for mild COVID-19 cases; consider it the best bet for early treatment of COVID-19.

Mumbai, January 26, 2022: With questions being raised on the safety of the only available approved oral antiviral pill for COVID-19…

3 years ago

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

New Delhi, July 22, 2020: Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and…

4 years ago

North America to Dominate Drug Delivery Devices Market During Forecast Period – TechSci Research

Rising prevalence of chronic diseases is expected to drive the growth of global drug delivery devices market New Delhi, July…

4 years ago

Chemistry breakthrough could speed up drug development

Scientists have successfully developed a new technique to reliably grow crystals of organic soluble molecules from nanoscale droplets, unlocking the…

4 years ago

Eisai Center for Genetics Guided Dementia Discovery Commences Full-Scale Operation Toward Innovative Dementia Treatments With New Drug Discovery Approach in Cambridge, Massachusetts

A Focused Drug Discovery Approach That Integrates Human Genetics/ Data Science/ Precision Chemistry Tokyo, July 10, 2019: Eisai Co., Ltd.…

5 years ago

Eisai’s Supplementary New Drug Application Submitted In Japan for Fycompa

As Monotherapy for Partial-Onset Seizures, Pediatric Indication for Partial-Onset Seizures, as Well as New Formulation Tokyo, February 03, 2019: Eisai Co., Ltd.…

6 years ago

Panav Bio-Tech Introduces Classical Swine Fever – Himmvac Hog Cholera (T/C) Vaccine in India

New Delhi, December 06, 2018: Panav Bio-Tech, a leading company in the animal healthcare, is now offering a vaccine for classical…

6 years ago

France Telemedicine Outlook to 2022: Ken Research

New Delhi, November 17, 2018: The report titled “France Telemedicine Outlook to 2022- By Services and Technology, By Service Platform…

6 years ago

MedGenome study suggests a personalized cancer vaccine approach to treat Lynch Syndrome

National, September 06, 2018: A breakthrough study on ‘cancer vaccine approach for personalized treatment of Lynch Syndrome’ by MedGenome was…

6 years ago

Cadila Healthcare divests its entire stake in Bremer Pharma, Germany

Mumbai, April 20, 2018: Cadila Healthcare said that company has divested its entire shareholding in Bremer Pharma GmbH, Germany (Bremer),…

7 years ago